FDA Greenlights 'Breakthrough' Alzheimer's Drug Amid Risk and Cost Concerns
Jul 8th 2023 2:52pm EDT
Leqembi, a breakthrough drug for Alzheimer’s disease, as received the FDA’s nod for use, but medical experts caution about potential side effects, and call for training medical professionals before use.
Discuss on Nostr!
Nostr Note ID note1hhnemurqfve70raqvtxg7knys9htp37u5wlzeqv6v7k33ucvvt5s843q78 Open on Primal.net Open on Snort.social Open on Iris.to Open on Coracle.social
New to Nostr?
Create an account now & join the conversation!
Promote it on DissentWatch!
- To advertise this post for $0.02 per visit send bitcoins to the address below
- The post will be promoted daily via social media & our "Featured News" display in multiple places
- You can add more anytime
- Ranking order in the Featured News box is based on the balance remaining
Received: 0 mBTC (0.00 USD)
Spent: 0 mBTC (0.00 USD)
Balance: 0 mBTC (0.00 USD)
The amounts above may be lagging behind. If you just sent a payment click below to get more up to date results and push the post to the "Featured News" box faster.